These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 37036031
1. Acceptability, feasibility and preliminary efficacy of low-moderate intensity Constraint Induced Aphasia Therapy and Multi-Modality Aphasia Therapy in chronic aphasia after stroke. Pierce JE, OHalloran R, Togher L, Nickels L, Copland D, Godecke E, Meinzer M, Rai T, Cadilhac DA, Kim J, Hurley M, Foster A, Carragher M, Wilcox C, Steel G, Rose ML. Top Stroke Rehabil; 2024 Jan; 31(1):44-56. PubMed ID: 37036031 [Abstract] [Full Text] [Related]
2. Results of the COMPARE trial of Constraint-induced or Multimodality Aphasia Therapy compared with usual care in chronic post-stroke aphasia. Rose ML, Nickels L, Copland D, Togher L, Godecke E, Meinzer M, Rai T, Cadilhac DA, Kim J, Hurley M, Foster A, Carragher M, Wilcox C, Pierce JE, Steel G. J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):573-581. PubMed ID: 35396340 [Abstract] [Full Text] [Related]
3. Statistical analysis plan for the COMPARE trial: a 3-arm randomised controlled trial comparing the effectiveness of Constraint-induced Aphasia Therapy Plus and Multi-modality Aphasia Therapy to usual care in chronic post-stroke aphasia (COMPARE). Rose ML, Rai T, Copland D, Nickels L, Togher L, Meinzer M, Godecke E, Kim J, Cadilhac DA, Hurley M, Wilcox C, Carragher M. Trials; 2021 Apr 23; 22(1):303. PubMed ID: 33892764 [Abstract] [Full Text] [Related]
4. Constraint-induced or multi-modal personalized aphasia rehabilitation (COMPARE): A randomized controlled trial for stroke-related chronic aphasia. Rose ML, Copland D, Nickels L, Togher L, Meinzer M, Rai T, Cadilhac DA, Kim J, Foster A, Carragher M, Hurley M, Godecke E. Int J Stroke; 2019 Dec 23; 14(9):972-976. PubMed ID: 31496440 [Abstract] [Full Text] [Related]
5. High-Intensity Aphasia Therapy Is Cost-Effective in People With Poststroke Aphasia: Evidence From the COMPARE Trial. Kim J, Rose ML, Pierce JE, Nickels L, Copland DA, Togher L, Godecke E, Meinzer M, Rai T, Hurley M, Foster A, Carragher M, Wilcox C, Cadilhac DA. Stroke; 2024 Mar 23; 55(3):705-714. PubMed ID: 38328930 [Abstract] [Full Text] [Related]
6. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial. Palmer R, Dimairo M, Cooper C, Enderby P, Brady M, Bowen A, Latimer N, Julious S, Cross E, Alshreef A, Harrison M, Bradley E, Witts H, Chater T. Lancet Neurol; 2019 Sep 23; 18(9):821-833. PubMed ID: 31397288 [Abstract] [Full Text] [Related]
7. Constraint-Induced Aphasia Therapy for Treatment of Chronic Post-Stroke Aphasia: A Randomized, Blinded, Controlled Pilot Trial. Szaflarski JP, Ball AL, Vannest J, Dietz AR, Allendorfer JB, Martin AN, Hart K, Lindsell CJ. Med Sci Monit; 2015 Sep 24; 21():2861-9. PubMed ID: 26399192 [Abstract] [Full Text] [Related]
8. High-Intensity Aphasia Intervention Is Minimally Fatiguing in Chronic Aphasia: An Analysis of Participant Self-Ratings From a Large Randomized Controlled Trial. Pierce JE, Cavanaugh R, Harvey S, Dickey MW, Nickels L, Copland D, Togher L, Godecke E, Meinzer M, Rai T, Cadilhac DA, Kim J, Hurley M, Foster AM, Carragher M, Wilcox C, Rose ML. Stroke; 2024 Jul 24; 55(7):1877-1885. PubMed ID: 38836352 [Abstract] [Full Text] [Related]
9. Effect of type of language therapy on expressive language skills in patients with post-stroke aphasia. Vuksanović J, Milovanović T, Konstantinović L, Filipović SR. Int J Lang Commun Disord; 2018 Jul 24; 53(4):825-835. PubMed ID: 29749688 [Abstract] [Full Text] [Related]
10. A feasibility study of combined intermittent theta burst stimulation and modified constraint-induced aphasia therapy in chronic post-stroke aphasia. Szaflarski JP, Griffis J, Vannest J, Allendorfer JB, Nenert R, Amara AW, Sung V, Walker HC, Martin AN, Mark VW, Zhou X. Restor Neurol Neurosci; 2018 Jul 24; 36(4):503-518. PubMed ID: 29889086 [Abstract] [Full Text] [Related]
11. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial. Baumgaertner A, Grewe T, Ziegler W, Floel A, Springer L, Martus P, Breitenstein C. Trials; 2013 Sep 23; 14():308. PubMed ID: 24059983 [Abstract] [Full Text] [Related]
12. Constraint-induced aphasia therapy following sub-acute stroke: a single-blind, randomised clinical trial of a modified therapy schedule. Sickert A, Anders LC, Münte TF, Sailer M. J Neurol Neurosurg Psychiatry; 2014 Jan 23; 85(1):51-5. PubMed ID: 23828834 [Abstract] [Full Text] [Related]
13. A randomized controlled trial of very early rehabilitation in speech after stroke. Godecke E, Armstrong EA, Rai T, Middleton S, Ciccone N, Whitworth A, Rose M, Holland A, Ellery F, Hankey GJ, Cadilhac DA, Bernhardt J. Int J Stroke; 2016 Jul 23; 11(5):586-92. PubMed ID: 27151156 [Abstract] [Full Text] [Related]
14. Constraint-induced aphasia therapy in post-stroke aphasia rehabilitation: A systematic review and meta-analysis of randomized controlled trials. Zhang J, Yu J, Bao Y, Xie Q, Xu Y, Zhang J, Wang P. PLoS One; 2017 Jul 23; 12(8):e0183349. PubMed ID: 28846724 [Abstract] [Full Text] [Related]
15. Constraint-Induced Aphasia Therapy in the Acute Stage: What Is the Key Factor for Efficacy? A Randomized Controlled Study. Woldag H, Voigt N, Bley M, Hummelsheim H. Neurorehabil Neural Repair; 2017 Jan 23; 31(1):72-80. PubMed ID: 27506677 [Abstract] [Full Text] [Related]
16. Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis. RELEASE Collaborators, Brady MC, Ali M, VandenBerg K, Williams LJ, Williams LR, Abo M, Becker F, Bowen A, Brandenburg C, Breitenstein C, Bruehl S, Copland DA, Cranfill TB, Pietro-Bachmann MD, Enderby P, Fillingham J, Lucia Galli F, Gandolfi M, Glize B, Godecke E, Hawkins N, Hilari K, Hinckley J, Horton S, Howard D, Jaecks P, Jefferies E, Jesus LM, Kambanaros M, Kyoung Kang E, Khedr EM, Pak-Hin Kong A, Kukkonen T, Laganaro M, Lambon Ralph MA, Charlotte Laska A, Leemann B, Leff AP, Lima RR, Lorenz A, MacWhinney B, Shisler Marshall R, Mattioli F, Maviş İ, Meinzer M, Nilipour R, Noé E, Paik NJ, Palmer R, Papathanasiou I, Patricio B, Pavão Martins I, Price C, Prizl Jakovac T, Rochon E, Rose ML, Rosso C, Rubi-Fessen I, Ruiter MB, Snell C, Stahl B, Szaflarski JP, Thomas SA, van de Sandt-Koenderman M, van der Meulen I, Visch-Brink E, Worrall L, Harris Wright H. Int J Stroke; 2022 Dec 23; 17(10):1067-1077. PubMed ID: 35422175 [Abstract] [Full Text] [Related]
17. A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study. Godecke E, Armstrong E, Rai T, Ciccone N, Rose ML, Middleton S, Whitworth A, Holland A, Ellery F, Hankey GJ, Cadilhac DA, Bernhardt J, VERSE Collaborative Group. Int J Stroke; 2021 Jul 23; 16(5):556-572. PubMed ID: 33019888 [Abstract] [Full Text] [Related]
18. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Berthier ML, Green C, Lara JP, Higueras C, Barbancho MA, Dávila G, Pulvermüller F. Ann Neurol; 2009 May 23; 65(5):577-85. PubMed ID: 19475666 [Abstract] [Full Text] [Related]
19. Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis. REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) CollaboratorsListed in the Appendix.. Stroke; 2022 Mar 23; 53(3):956-967. PubMed ID: 34847708 [Abstract] [Full Text] [Related]
20. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Breitenstein C, Grewe T, Flöel A, Ziegler W, Springer L, Martus P, Huber W, Willmes K, Ringelstein EB, Haeusler KG, Abel S, Glindemann R, Domahs F, Regenbrecht F, Schlenck KJ, Thomas M, Obrig H, de Langen E, Rocker R, Wigbers F, Rühmkorf C, Hempen I, List J, Baumgaertner A, FCET2EC study group. Lancet; 2017 Apr 15; 389(10078):1528-1538. PubMed ID: 28256356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]